Jack Lancaster

Jack Lancaster serves as Chief Executive Officer at Evolution Surgical. Evolution Surgical operates in the medical devices sector with approximately 36.0 employees. The company is headquartered in Sydney, New South Wales.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • 3,176 executive contacts are available in New South Wales.
• • Our database includes 201,468 c suite-level executives.

Cloudflare DNS Gmail Outlook Google Apps Amazon AWS WordPress.org Mobile Friendly Cedexis Radar Woo Commerce Adobe Media Optimizer Vimeo Google Font API Remote

spine surgery medtech surgical innovation anterior cervical posterior cervical anterior column interbody posterior lumbar interbody thoracolumbar stabilization biologics vertebral body replacement surgical implants patient care surgical outcomes quality control design & manufacturing surgical instruments regulatory compliance surgical technology australian medtech full product lifecycle patient value clinical support surgery collaboration feedback integration local r&d biomedical engineering surgical expertise surgeon partnerships medical training extractable data clinical effectiveness surgery solutions healthcare industry product development device innovation surgical techniques safety & efficacy patient outcomes spinal implants orthopaedics neurosurgery surgical research surgical precision australian jobs surgical products surgical standards iso certification spinal disease treatment surgical training

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Jack Lancaster in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Evolution Surgical.

Jack Lancaster's Position in the MessageCEO Database

• •Jack Lancaster is 1 of 1 verified executive contact we track at Evolution Surgical.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •3,103 verified executive contacts in New South Wales are in the database.
• •17 verified contacts work at medical devices companies in the 36.0 employee range (same size as Evolution Surgical).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Jack Lancaster directly?

Jack Lancaster's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Evolution Surgical. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Jack Lancaster work for?

Jack Lancaster is Chief Executive Officer at Evolution Surgical, a company in the medical devices sector with 36.0 employees. The company is based in Sydney, New South Wales.

Can I pitch or sell to Jack Lancaster?

As Chief Executive Officer at Evolution Surgical, Jack Lancaster is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Jack Lancaster directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Jack Lancaster in?

Jack Lancaster works in the medical devices industry as Chief Executive Officer at Evolution Surgical. MessageCEO provides verified contact information for executives across all major industries.

Is Jack Lancaster's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Jack Lancaster's profile is kept up-to-date with the latest available information.

Last updated: July 31, 2026